Keep an Eye on Protein Kinase InhibitorsByAmy Lee, PharmD Candidate,Matthew P. Pietry, PharmD Candidate,Amy T. Murdico, PharmD, BCPS,Jeffrey Fudin, PharmD, FCCP, FASHP, FFSMBSeptember 30th 2019Medications in this drug class can alter the safety and efficacy of co-administered medications.